← Leaderboards
Andrea Gabriela Lopez-Arroyo
Albert Einstein College Of Medicine, Inc
$89,541
Attributed
$89,541
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45K · FY2018–20$50K$37.5K$25K$12.5K$0
'18
'19
'20
Funding mix
By agency
NIH$89,541 · 1
By mechanism
F31$89,541 · 1
Top collaborators
No co-investigators on record.
Most similar at Albert Einstein College Of Medicine, Inc
Same institution · by research overlap
- Thomas Julian Ow$852,780
- Jun Yoshioka$3,131,975
Others in their field
Other Emerging Leaders on “Affinity”
- Bala Raja · Luminostics, Inc.$28,624,460
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$25,726,378
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Timothy M Willson · University Of Cape Town$13,865,323
Research focus
AffinityAntitumor EffectApoptosisApoptoticBaseBax GeneBax ProteinBcl1 OncogeneBcl2 GeneBcl-2 ProteinBcl-Xlong ProteinCancer CellCancer Cell LineCancer ModelCancer PatientCancer TherapyCancer TypeCell DeathCell LineCellsCell SurvivalChemotherapyClinical DevelopmentClinical Trials
Grant awards (4)
Synergistic co-targeting of pro-apoptotic BAX and anti-apoptotic BCL-XL in cancer$1
F31 · FY2020 · CA · contact PI
Synergistic co-targeting of pro-apoptotic BAX and anti-apoptotic BCL-XL in cancer$45,016
F31 · FY2019 · CA · contact PI
Synergistic co-targeting of pro-apoptotic BAX and anti-apoptotic BCL-XL in cancer$28,568
F31 · FY2018 · CA · contact PI
Synergistic co-targeting of pro-apoptotic BAX and anti-apoptotic BCL-XL in cancer$15,956
F31 · FY2018 · CA · contact PI